Garrison Asset Management, LLC Bristol Myers Squibb CO Transaction History

Garrison Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 04, 2020	SELL	$46.4 - $67.43 $153,027 - $222,384	-3,298 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $162,294 - $211,698	3,298 New	3,298 $212,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $162,955 - $211,314	-3,342 Closed	0 $0
Q3 2018 Nov 02, 2018	BUY	$55.19 - $62.25 $184,444 - $208,039	3,342 New	3,342 $207,000

2,435

1.51B

29.7M

32.1M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $112B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Garrison Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Garrison Asset Management, LLC with notifications on news.